A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

According to the current clinical practice guidelines for chronic obstructive pulmonary disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β(2) agonist therapy is recommended in patients with moderate-to-severe disease and an increased risk of exacerbations. However, ICS ar...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Respir Res
Päätekijät: Miravitlles, Marc, Cosío, Borja G., Arnedillo, Aurelio, Calle, Myriam, Alcázar-Navarrete, Bernardino, González, Cruz, Esteban, Cristóbal, Trigueros, Juan Antonio, Rodríguez González-Moro, José Miguel, Quintano Jiménez, José Antonio, Baloira, Adolfo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706374/
https://ncbi.nlm.nih.gov/pubmed/29183382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0682-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia